Skip to main content
Erschienen in: Supportive Care in Cancer 10/2017

14.07.2017 | Commentary

Nutritional support for cancer patients: still a neglected right?

verfasst von: Riccardo Caccialanza, Francesco De Lorenzo, Luca Gianotti, Vittorina Zagonel, Cecilia Gavazzi, Gabriella Farina, Paolo Cotogni, Saverio Cinieri, Emanuele Cereda, Paolo Marchetti, Mariateresa Nardi, Elisabetta Iannelli, Claudia Santangelo, Francesca Traclò, Carmine Pinto, Paolo Pedrazzoli

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Excerpt

Malnutrition is a frequent problem in cancer patients, the prevalence and degree of which primarily depend on tumor stage and site [1]. Its negative consequences are prolonged hospitalization, a greater degree of treatment-related toxicity, reduced response to cancer treatment, lower activity level, impaired quality of life, and a worse overall prognosis [2]. …
Literatur
1.
Zurück zum Zitat Hébuterne X, Lemarié E, Michallet M et al (2014) Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN 38:196–204CrossRef Hébuterne X, Lemarié E, Michallet M et al (2014) Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN 38:196–204CrossRef
2.
Zurück zum Zitat Van Cutsem E, Arends J (2005) The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9:S51–S63CrossRefPubMed Van Cutsem E, Arends J (2005) The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9:S51–S63CrossRefPubMed
3.
Zurück zum Zitat Prado CM, Antoun S, Sawyer MB, Baracos VE (2011) Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity. Curr Opin Clin Nutr Metab Care 14:250–254CrossRefPubMed Prado CM, Antoun S, Sawyer MB, Baracos VE (2011) Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity. Curr Opin Clin Nutr Metab Care 14:250–254CrossRefPubMed
4.
Zurück zum Zitat Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T (2015) Loss of lean body mass as an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol 22:2560–2566CrossRefPubMed Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T (2015) Loss of lean body mass as an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol 22:2560–2566CrossRefPubMed
5.
Zurück zum Zitat Jung HW, Kim JW, Kim JY, Kim SW, Yang HK, Lee JW, Lee KW, Kim DW, Kang SB, Kim KI, Kim CH, Kim JH (2015) Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer 23:687–694CrossRefPubMed Jung HW, Kim JW, Kim JY, Kim SW, Yang HK, Lee JW, Lee KW, Kim DW, Kang SB, Kim KI, Kim CH, Kim JH (2015) Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer 23:687–694CrossRefPubMed
6.
Zurück zum Zitat Strulov Shachar S, Deal AM, Weinberg M, Nyrop KA, Williams GR, Nishijima TF, Benbow JM, Muss HB (2017) Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy. Clin Cancer Res 23:658–665CrossRef Strulov Shachar S, Deal AM, Weinberg M, Nyrop KA, Williams GR, Nishijima TF, Benbow JM, Muss HB (2017) Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy. Clin Cancer Res 23:658–665CrossRef
7.
Zurück zum Zitat Suzuki Y, Okamoto T, Fujishita T, Katsura M, Akamine T, Takamori S, Morodomi Y, Tagawa T, Shoji F, Maehara Y (2016) Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer. Lung Cancer 101:92–97CrossRefPubMed Suzuki Y, Okamoto T, Fujishita T, Katsura M, Akamine T, Takamori S, Morodomi Y, Tagawa T, Shoji F, Maehara Y (2016) Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer. Lung Cancer 101:92–97CrossRefPubMed
8.
Zurück zum Zitat Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36:11–48CrossRefPubMed Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36:11–48CrossRefPubMed
9.
Zurück zum Zitat Gavazzi C, Colatruglio S, Valoriani F, Mazzaferro V, Sabbatini A, Biffi R, Mariani L, Miceli R (2016) Impact of home enteral nutrition in malnourished patients with upper gastrointestinal cancer: a multicentre randomised clinical trial. Eur J Cancer 64:107–112CrossRefPubMed Gavazzi C, Colatruglio S, Valoriani F, Mazzaferro V, Sabbatini A, Biffi R, Mariani L, Miceli R (2016) Impact of home enteral nutrition in malnourished patients with upper gastrointestinal cancer: a multicentre randomised clinical trial. Eur J Cancer 64:107–112CrossRefPubMed
10.
Zurück zum Zitat Qiu M, Zhou YX, Jin Y, Wang ZX, Wei XL, Han HY, Ye WF, Zhou ZW, Zhang DS, Wang FH, Li YH, Yang DJ, Xu RH (2015) Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy. Support Care Cancer 23(7):1933–1939CrossRefPubMed Qiu M, Zhou YX, Jin Y, Wang ZX, Wei XL, Han HY, Ye WF, Zhou ZW, Zhang DS, Wang FH, Li YH, Yang DJ, Xu RH (2015) Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy. Support Care Cancer 23(7):1933–1939CrossRefPubMed
11.
Zurück zum Zitat Spiro A, Baldwin C, Patterson A et al (2006) The views and practice of oncologists towards nutritional support in patients receiving chemotherapy. Br J Cancer 95:431–434CrossRefPubMedPubMedCentral Spiro A, Baldwin C, Patterson A et al (2006) The views and practice of oncologists towards nutritional support in patients receiving chemotherapy. Br J Cancer 95:431–434CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Martin L, de van der Schueren MA, Blauwhoff-Buskermolen S, Baracos V, Gramlich L (2016) Identifying the barriers and enablers to nutrition care in head and neck and esophageal cancers: an international qualitative study. JPEN 40:355–366CrossRef Martin L, de van der Schueren MA, Blauwhoff-Buskermolen S, Baracos V, Gramlich L (2016) Identifying the barriers and enablers to nutrition care in head and neck and esophageal cancers: an international qualitative study. JPEN 40:355–366CrossRef
13.
Zurück zum Zitat Caccialanza R, Cereda E, Pinto C, Cotogni P, Farina G, Gavazzi C, Gandini C, Nardi M, Zagonel V, Pedrazzoli P (2016) Awareness and consideration of malnutrition among oncologists: insights from an exploratory survey. Nutrition 32:1028–1032CrossRefPubMed Caccialanza R, Cereda E, Pinto C, Cotogni P, Farina G, Gavazzi C, Gandini C, Nardi M, Zagonel V, Pedrazzoli P (2016) Awareness and consideration of malnutrition among oncologists: insights from an exploratory survey. Nutrition 32:1028–1032CrossRefPubMed
14.
Zurück zum Zitat Sierpina V, Levine L, McKee J et al (2015) Nutrition, metabolism, and integrative approaches in cancer survivors. Semin Oncol Nurs 31:42–52CrossRefPubMed Sierpina V, Levine L, McKee J et al (2015) Nutrition, metabolism, and integrative approaches in cancer survivors. Semin Oncol Nurs 31:42–52CrossRefPubMed
15.
Zurück zum Zitat Bhaskar AK (2012) Interventional management of cancer pain. Curr Opin Support Palliat Care 6:1–9CrossRefPubMed Bhaskar AK (2012) Interventional management of cancer pain. Curr Opin Support Palliat Care 6:1–9CrossRefPubMed
16.
Zurück zum Zitat Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS (2012) Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol 30:1980–1988CrossRefPubMedPubMedCentral Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS (2012) Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol 30:1980–1988CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Zagonel V, Torta R, Franciosi V, Brunello A, Biasco G, Cattaneo D, Cavanna L, Corsi D, Farina G, Fioretto L, Gamucci T, Lanzetta G, Magarotto R, Maltoni M, Mastromauro C, Melotti B, Meriggi F, Pavese I, Piva E, Sacco C, Tonini G, Trentin L, Ermacora P, Varetto A, Merlin F, Gori S, Cascinu S, Pinto C, AIOM Simultaneous & Continuous Care (SCC) Task Force-ESMO-DCs (2016) Early integration of palliative care in oncology practice: results of the Italian Association of Medical Oncology (AIOM) Survey. J Cancer 7:1968–1978CrossRefPubMedPubMedCentral Zagonel V, Torta R, Franciosi V, Brunello A, Biasco G, Cattaneo D, Cavanna L, Corsi D, Farina G, Fioretto L, Gamucci T, Lanzetta G, Magarotto R, Maltoni M, Mastromauro C, Melotti B, Meriggi F, Pavese I, Piva E, Sacco C, Tonini G, Trentin L, Ermacora P, Varetto A, Merlin F, Gori S, Cascinu S, Pinto C, AIOM Simultaneous & Continuous Care (SCC) Task Force-ESMO-DCs (2016) Early integration of palliative care in oncology practice: results of the Italian Association of Medical Oncology (AIOM) Survey. J Cancer 7:1968–1978CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA, Back AL, Kamdar M, Jacobsen J, Chittenden EH, Rinaldi SP, Gallagher ER, Eusebio JR, Li Z, Muzikansky A, Ryan DP (2017) Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol 35:834–841CrossRefPubMed Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA, Back AL, Kamdar M, Jacobsen J, Chittenden EH, Rinaldi SP, Gallagher ER, Eusebio JR, Li Z, Muzikansky A, Ryan DP (2017) Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol 35:834–841CrossRefPubMed
19.
Zurück zum Zitat Amano K, Maeda I, Morita T, Okajima Y, Hama T, Aoyama M, Kizawa Y, Tsuneto S, Shima Y, Miyashita M (2016) Eating-related distress and need for nutritional support of families of advanced cancer patients: a nationwide survey of bereaved family members. J Cachexia Sarcopenia Muscle 7:527–534CrossRefPubMedPubMedCentral Amano K, Maeda I, Morita T, Okajima Y, Hama T, Aoyama M, Kizawa Y, Tsuneto S, Shima Y, Miyashita M (2016) Eating-related distress and need for nutritional support of families of advanced cancer patients: a nationwide survey of bereaved family members. J Cachexia Sarcopenia Muscle 7:527–534CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Caccialanza R, Pedrazzoli P, Cereda E, Gavazzi C, Pinto C, Paccagnella A et al (2016) Nutritional support in cancer patients: a position paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE). J Cancer 7:131–135CrossRefPubMedPubMedCentral Caccialanza R, Pedrazzoli P, Cereda E, Gavazzi C, Pinto C, Paccagnella A et al (2016) Nutritional support in cancer patients: a position paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE). J Cancer 7:131–135CrossRefPubMedPubMedCentral
Metadaten
Titel
Nutritional support for cancer patients: still a neglected right?
verfasst von
Riccardo Caccialanza
Francesco De Lorenzo
Luca Gianotti
Vittorina Zagonel
Cecilia Gavazzi
Gabriella Farina
Paolo Cotogni
Saverio Cinieri
Emanuele Cereda
Paolo Marchetti
Mariateresa Nardi
Elisabetta Iannelli
Claudia Santangelo
Francesca Traclò
Carmine Pinto
Paolo Pedrazzoli
Publikationsdatum
14.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2017
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3826-1

Weitere Artikel der Ausgabe 10/2017

Supportive Care in Cancer 10/2017 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.